GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Cyclically Adjusted PB Ratio

Whanin Pharm Co (XKRX:016580) Cyclically Adjusted PB Ratio : (As of Sep. 21, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Whanin Pharm Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Whanin Pharm Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Cyclically Adjusted PB Ratio Chart

Whanin Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.16 1.16 1.12 1.00 0.79

Whanin Pharm Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.74 0.79 0.75 -

Competitive Comparison of Whanin Pharm Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Whanin Pharm Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Whanin Pharm Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Whanin Pharm Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Whanin Pharm Co's Cyclically Adjusted PB Ratio falls into.



Whanin Pharm Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Whanin Pharm Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Whanin Pharm Co's adjusted Book Value per Share data for the three months ended in Jun. 2024 was:

Adj_Book=Book Value per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=24168.273/*
=

Current CPI (Jun. 2024) = .

Whanin Pharm Co Quarterly Data

Book Value per Share CPI Adj_Book
201409 12,054.521 99.608 0.000
201412 12,348.220 99.098 0.000
201503 12,360.829 99.720 0.000
201506 12,916.234 100.050 0.000
201509 13,242.241 100.110 0.000
201512 13,531.989 100.220 0.000
201603 13,607.048 100.560 0.000
201606 14,053.269 100.790 0.000
201609 14,344.305 101.460 0.000
201612 14,418.538 101.560 0.000
201703 14,647.690 102.850 0.000
201706 15,160.701 102.610 0.000
201709 15,468.613 103.490 0.000
201712 15,922.051 102.990 0.000
201803 16,166.099 104.100 0.000
201806 16,457.110 104.130 0.000
201809 16,888.413 105.650 0.000
201812 17,002.866 104.350 0.000
201903 17,206.393 104.490 0.000
201906 17,394.165 104.880 0.000
201909 17,724.912 105.200 0.000
201912 17,932.503 105.120 0.000
202003 17,868.757 105.540 0.000
202006 18,337.059 104.870 0.000
202009 18,925.072 106.200 0.000
202012 19,395.619 105.765 0.000
202103 19,649.857 107.357 0.000
202106 20,172.433 107.579 0.000
202109 20,581.842 108.759 0.000
202112 20,759.635 109.676 0.000
202203 21,008.961 111.806 0.000
202206 21,179.194 114.083 0.000
202209 21,434.224 114.831 0.000
202212 21,845.103 115.200 0.000
202303 22,034.134 116.550 0.000
202306 22,568.028 117.140 0.000
202309 22,957.578 119.111 0.000
202312 23,462.706 118.848 0.000
202403 23,742.761 118.848 0.000
202406 24,168.273 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Whanin Pharm Co  (XKRX:016580) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Whanin Pharm Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Whanin Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co Headlines

No Headlines